{"disease":{"id":"distal-cholangiocarcinoma","name":"distal cholangiocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06671431","title":"Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":578,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05478889","title":"Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":478,"lead_sponsor_name":"Fondazione Poliambulanza Istituto Ospedaliero","has_results":false},{"nct_id":"NCT03768414","title":"Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT06923475","title":"Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT06717464","title":"Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT07328607","title":"Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT05564403","title":"Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":66,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04941287","title":"Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05251233","title":"Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":56,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT05239169","title":"Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","has_results":false},{"nct_id":"NCT05641233","title":"Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":33,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT05595122","title":"EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT05285358","title":"Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"City of Hope Medical Center","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}